Page last updated: 2024-11-07

dehydroepiandrosterone and Atherosclerotic Parkinsonism

dehydroepiandrosterone has been researched along with Atherosclerotic Parkinsonism in 2 studies

Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choe, MA1
An, GJ1
Koo, BS1
Jeon, S1
Bélanger, N1
Grégoire, L1
Bédard, P1
Di Paolo, T1

Other Studies

2 other studies available for dehydroepiandrosterone and Atherosclerotic Parkinsonism

ArticleYear
Effect of DHEA on recovery of muscle atrophy induced by Parkinson's disease.
    Journal of Korean Academy of Nursing, 2011, Volume: 41, Issue:6

    Topics: Animals; Corpus Striatum; Dehydroepiandrosterone; Extracellular Signal-Regulated MAP Kinases; Male;

2011
Estradiol and dehydroepiandrosterone potentiate levodopa-induced locomotor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.
    Endocrine, 2003, Volume: 21, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dehydroepiandrosterone; Dopamine Agents; Dose

2003